ApoQlar Secures Funding through Partnership with YZR

ApoQlar Secures Funding through Partnership with YZR

Spread the love

ApoQlar, an avant-garde med-tech company, has successfully secured seed funding led by YZR, a venture capital firm that specializes in making investments in health-tech companies. This newly secured investment endorses the futuristic potentials of apoQlar’s newly launched augmented reality platform, VSI HoloMedicine.

The funding will particularly be used to speed up the development of the company’s latest software-VSI HoloMedicine version 2.0. This will continually increase education in medicine, patient outcomes, and surgical planning. 

“We are thrilled to have received funding from YZR, a leading German venture capital firm in the health tech space,” said Sirko Pelzl, CEO and co-founder at apoQlar.”This investment not only validates the potential of our augmented reality platform but also highlights the importance of our mission to improve surgical care. We are confident in our ability to drive innovation, expand our reach, and make a significant impact on the healthcare industry globally.”

The company’s partnership with YZR will allow it to advance its augmented reality technology, boost its presence in the market, and increase its global footprint. In addition, it will promote apoQlar’s cooperative efforts with surgical teams and providers, which are geared towards improving patient outcomes and surgical practices. 

Following its significant partnership with venture capital firm, YHZ, apoQlar also partnered with firms like the Infocomm Media Development Authority (IMDA) and Microsoft in Singapore to implement the HoloMedicine (a part of the NUHS HoloMedicine Program), and the National University Health System (NUHS) 

Furthermore, this cooperative enterprise employs Azure private multi-access edge computer (MEC), Azure private cloud, and 5G technology. 

All of these allow surgeons to seamlessly take advantage of the enthralling capabilities of the VSI HoloMedicine platform. The platform is successfully accessed through mixed-reality headsets like HoloLens 2 and other XR devices. 

“We are proud to be part of the NUHS HoloMedicine® ASAP program,” added Sirko Pelzl. “This collaboration represents a significant step forward in utilizing technology to elevate patient care and revolutionize the field of medicine. We believe this groundbreaking initiative will inspire healthcare institutions worldwide to adopt augmented reality solutions and drive innovation.”

Follow us on LinkedIn

Read other Articles

Spread the love

Leave a Reply